| Income Statement |
| Total Revenue | 259.96M |
|
| Revenues (USD) | 259.96M |
| Cost of Revenue | 173.06M |
| Gross Profit | 86.90M |
| Operating Expenses | 46.43M |
| Research and Development Expense | 10.87M |
| Selling, General and Administrative Expense | 35.56M |
| Operating Income | 40.47M |
| Interest Expense | 2.33M |
| Income Tax Expense | 2.79M |
| Net Income | 35.06M |
| Net Income Common Stock | 35.06M |
| Net Income Common Stock (USD) | 35.06M |
| Consolidated Income | 35.06M |
| Earnings per Basic Share | 0.82 |
| Earnings per Basic Share (USD) | 0.82 |
| Earnings per Diluted Share | 0.75 |
| Earning Before Interest & Taxes (EBIT) | 40.19M |
| Earning Before Interest & Taxes (USD) | 40.19M |
| Weighted Average Shares | 35.84M |
| Balance Sheet |
| Cash and Equivalents | 9.02M |
| Cash and Equivalents (USD) | 9.02M |
| Trade and Non-Trade Receivables | 228.90M |
| Current Assets | 485.74M |
| Property, Plant & Equipment Net | 146.84M |
| Total Assets | 760.84M |
| Debt Current | 5.93M |
| Total Debt | 352.97M |
| Current Liabilities | 163.38M |
| Debt Non-Current | 347.04M |
| Total Liabilities | 562.62M |
| Accumulated Other Comprehensive Income | -6.11M |
| Shareholders Equity | 198.22M |
| Shareholders Equity (USD) | 198.22M |
| Assets Non-Current | 275.10M |
| Total Debt (USD) | 352.97M |
| Deferred Revenue | 26.59M |
| Goodwill and Intangible Assets | 113.89M |
| Inventory | 220.07M |
| Liabilities Non-Current | 399.24M |
| Trade and Non-Trade Payables | 64.40M |
| Cash Flow |
| Depreciation, Amortization & Accretion | 7.68M |
| Net Cash Flow from Financing | -27.16M |
| Net Cash Flow / Change in Cash & Cash Equivalents | -2.85M |
| Capital Expenditure | -5.71M |
| Issuance (Repayment) of Debt Securities | -25.00M |
| Net Cash Flow from Investing | -5.71M |
| Net Cash Flow from Operations | 30.12M |
| Effect of Exchange Rate Changes on Cash | -101.00K |
| Share Based Compensation | 2.26M |